Hyperbaric Oxygen Brain Injury Treatment Trial
Key facts
- Who runs it
- Gaylan Rockswold
- Where
- Baltimore, Columbus, Detroit, Durham, Iowa City, Lexington, Minneapolis, Omaha, San Diego, and West Palm Beach, United StatesSee the 10 sitesAlso in 1 other country, 1 site
- Trial code
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 200 people, planned
- Started
- 25 Jun 2018
- Expected to end
- 30 Jun 2029
- Type of study
- Interventional, 8 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Hyperbaric oxygen (1.5 ATA, no NBH)
- Hyperbaric oxygen (2.0 ATA, no NBH)
- Hyperbaric oxygen (2.5 ATA, no NBH)
- Hyperbaric oxygen (1.5 ATA + NBH)
- Hyperbaric oxygen (2.0 ATA + NBH)
- Hyperbaric oxygen (2.5 ATA + NBH)
- Normobaric Hyperoxia (NBH)
- Usual Care
- Record updated
- 2 June 2026
Who can take part
- Age
- 16 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Age 16 years or older and 65 years or younger
- Present with severe TBI, defined as Glasgow Coma Scale (GCS) of 3 to 8
- Marshall computerized tomography (CT) score >1 in patients with a GCS of 7 or 8 or patients with an alcohol level >200 mg/dl
- Ability to initiate the first hyperbaric oxygen treatment within 8 hours of admission in patients not requiring a craniotomy/craniectomy or any other major surgical procedure OR
- Ability to initiate the first hyperbaric oxygen treatment within 14 hours of admission in patients requiring a craniotomy/craniectomy or major surgical procedure
Who cannot take part
- Pre-existing neurologic disease (e.g. TBI or stroke or neurodegenerative disorder) with confounding residual neurologic deficits
- First hyperbaric oxygen treatment cannot be initiated within 24 hours of injury
- GCS of 3 with mid-position and non-reactive pupils bilaterally (4mm)
- Penetrating head injury
- Pregnant
- Unstable acute spinal cord injury
- Fixed coagulopathy
- Severe hypoxia
- Cardiopulmonary resuscitation performed
- Coma suspected to de due to primarily non-TBI causes
- Any contraindications to the study intervention
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 16 and 65 years old?
This trial is currently available in United States.
Also in 1 other country, 1 site
- University of MarylandBaltimore, United StatesContact: Leslie SultTaking people
- The Ohio State University -Wexner Medical CenterColumbus, United StatesContact: Gaylan L. Rockswold, M.D., Ph.D.No longer taking part
- Detroit Receiving HospitalDetroit, United StatesContact: Nick WesnerTaking people
- Duke University HospitalDurham, United StatesContact: Tammy HawleyTaking people
- University of Iowa Hospitals and ClinicsIowa City, United StatesContact: Catherine FairfieldTaking people
- University of Kentucky HospitalLexington, United StatesContact: Ronda A PETREYTaking people
- Hennepin County HospitalMinneapolis, United StatesContact: Jessica GiesekeTaking people
- University of Nebraska Medical CenterOmaha, United StatesContact: Gaylan L. Rockswold, M.D., Ph.D.No longer taking part
- UCSD Medical Center - Hillcrest HospitalSan Diego, United StatesContact: Lilian Von HusenTaking people
- St. Mary's Medical CenterWest Palm Beach, United StatesContact: Tracy RODRIGUEZTaking people
About the trial
What the trial wants to find out
The purpose of this innovative adaptive phase II trial design is to determine the optimal combination of hyperbaric oxygen treatment parameters that is most likely to demonstrate improvement in the outcome of severe TBI patients in a subsequent phase III trial.
The 8 groups in the trial
- Hyperbaric oxygen (1.5 ATA, no NBH)Treatment being tested
Hyperbaric oxygen at 1.5 ATA for 1 hour without NBH. This treatment is administered twice a day for 5 days.
- Hyperbaric oxygen (2.0 ATA, no NBH)Treatment being tested
Hyperbaric oxygen at 2.0 ATA for 1 hour without NBH. This treatment is administered twice a day for 5 days.
- Hyperbaric oxygen (2.5 ATA, no NBH)Treatment being tested
Hyperbaric oxygen at 2.5 ATA for 1 hour, without NBH. This treatment is administered twice a day for 5 days.
- Hyperbaric oxygen (1.5 ATA + NBH)Treatment being tested
Hyperbaric oxygen at 1.5 ATA for 1 hour and NBH for 3 hours. This treatment is administered twice a day for 5 days.
- Hyperbaric oxygen (2.0 ATA + NBH)Treatment being tested
Hyperbaric oxygen at 2.0 ATA for 1 hour and NBH for 3 hours. This treatment is administered twice a day for 5 days.
- Hyperbaric oxygen (2.5 ATA + NBH)Treatment being tested
Hyperbaric oxygen at 2.5 ATA for 1 hour and NBH for 3 hours. This treatment is administered twice a day for 5 days.
- Normobaric Hyperoxia (NBH)Treatment being tested
Normobaric Hyperoxia (NBH meaning 100% O2 at 1.0 ATA) for 4.5 hours twice a day for 5 days.
- Usual careExisting treatment, for comparison
Usual care for severe TBI
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial
- Criteria questions
- Built from NCT02407028, who can take part
- Record updated
- 2 June 2026